GlassScriptPhysician profile
Donnalyn Moeller
NPI 1568456630
$8,929.13
in general payments reported to CMS, 2019-2025
28 companies · $1,544 in 2025
The $1,544 reported for 2025 was more than what 87% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,066 · 2020: $139 · 2021: $345 · 2022: $1,328 · 2023: $2,001 · 2024: $1,507 · 2025: $1,544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,386 · Travel and Lodging: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,386.27 |
| Travel and Lodging | $665.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,635.79 | 2019-2023 | Mtp |
| Nevro Corp. | $1,293.93 | 2022-2024 | Senza |
| Smith+Nephew, INC. | $1,291.21 | 2021-2025 | Versajet, Grafix Pl, Stravix Pl |
| Horizon Therapeutics Plc | $958.55 | 2020-2023 | Krystexxa |
| Cdc Medical LLC | $618.60 | 2019-2023 | |
| Paratek Pharmaceuticals, INC. | $414.32 | 2022-2025 | Nuzyra |
| Globus Medical, INC. | $386.53 | 2025 | Senza |
| Kerecis Limited | $324.17 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Treace Medical Concepts, INC. | $307.18 | 2022-2025 | |
| Sanara Medtech INC. | $264.75 | 2024 | Celleraterx |
| Abbvie INC. | $247.44 | 2021-2023 | |
| Ets Wound Care LLC | $222.69 | 2025 | Mirragen Advanced Wound Matrix |
| Stryker Corporation | $172.19 | 2024 | Ortholoc 3di, Actishield, Ortholoc 2 Lapifuse |
| Nabriva Therapeutics, Plc | $153.18 | 2021-2022 | |
| Angiodynamics, INC. | $114.98 | 2023 | Auryon Laser System 100-120 Vac |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cosa Medical, LLC | $108.67 | 2025 | |
| Amgen INC. | $94.07 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $71.76 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $55.98 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $46.18 | 2022-2023 | Seglentis |
| Sebela Pharmaceuticals INC. | $28.87 | 2022 | |
| Solventum Corporation | $22.25 | 2025 | Activ.A.C. |
| Arteriocyte Medical Systems, INC. | $21.88 | 2025 | Magellan |
| Melinta Therapeutics, LLC | $19.33 | 2022 | |
| Amniox Medical, INC. | $16.72 | 2020 | |
| Convatec INC. | $13.98 | 2023 | |
| Orthofix Medical, INC. | $12.06 | 2025 | Physio-Stim |
| Pfizer INC. | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donnalyn Moeller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.